Sujan Ravi is a Gastroenterology physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 47 publications with 731 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
2 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
31.5%Bile Acid13.7%Ursodiol100%Part D≥21 patientsCorticosteroid7.9%Prednisone100%Part D≥11 patients+ 3 more classes in this area
Cancer & immunology
31.4%Calcineurin inhibitor25.4%Tacrolimus87%Cyclosporine Modified14%Part D<11 patientsPurine Antimetabolite5.9%Azathioprine100%Part D<11 patientsCardiovascular
28.1%Beta blocker11.5%Carvedilol61%Nadolol20%Propranolol Hcl19%Part D<11 patientsLoop diuretic7.9%Furosemide73%Bumetanide27%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Mean Arterial Pressure at Admission Predicts 28-day Mortality in Patients With Severe Alcohol-Associated Hepatitis
Clinical and Translational Gastroenterology
2026 - The risk of gastrointestinal bleeding with dual antiplatelet therapy in cirrhotics undergoing liver transplant evaluation
The American Journal of the Medical Sciences
2025 - S5311 From Banding to Bleeding: Rescue Therapy for Post-Banding Ulcer Bleeding (PBUB) Using Self-Expanding Metal Stents (SEMS)
The American Journal of Gastroenterology
2025 - S2531 Improving Care Pathways for Ascites: A Process Improvement Initiative to Reduce Short-Stay Admissions for Therapeutic Paracentesis
The American Journal of Gastroenterology
2025 - S2532 Improving Accuracy of Intake and Output Monitoring in Hospitalized Cirrhosis Patients: A Multidisciplinary Quality Improvement Initiative
The American Journal of Gastroenterology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Bruce Korf, MD
University of Alabama at Birmingham
Michael Mugavero, MD
University of Alabama at Birmingham
Charles Rice, MD
The Rockefeller University
Naga Chalasani, MD
Indiana University School of Medicine
Bruce Sands, MD
Icahn School of Medicine at Mount Sinai
Kris Kowdley, MD
Washington State University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”